Organic Chemistry TRIZ Cases

Boronic ester compounds modulate polymer association through reversible transesterification reactions to control lubricant viscosity.

Tricyclic compounds inhibit G9a and GLP enzymes, addressing the lack of effective treatments for cancers and hemoglobinopathies.

Lipophilic macrocyclic ligands stabilize radioactive metal complexes to prevent diffusion into sensitive organs while enabling precise tumor delivery.

Fused polycyclic organic semiconductor layers enhance carrier mobility through increased intermolecular interaction.

Formula I compounds selectively block Kv1.3 and Kv1.5 channels, reducing side effects from non-specific immunosuppression.

Segmented donor and acceptor blocks in vaporizable organic semiconductors resolve low exciton separation efficiency in thin-film solar cells.

A compound with high hole mobility facilitates efficient charge transport in organic electroluminescent devices.

Pyrimidine-2,4,6-trione compounds inhibit abnormal protein aggregation and modulate proteasome activity.

Novel non-purine compounds inhibit xanthine oxidase activity while avoiding severe hypersensitivity reactions linked to purine analogs.

Formula I compounds stabilize the SHP2 autoinhibited state to suppress tumor growth and treat disorders like leukemia.

A xylylenediisocyanate composition incorporates dichloromethyl benzyl isocyanate within defined concentration ranges to enhance resin stability.

Charge-transfer salt with ionic substituents enables solution processing of organic semiconductor layers.

A nucleic acid detection kit uses immobilized oligonucleotide primers to enable rolling circle amplification.

Topical compositions combine anti-inflammatory and antibacterial agents to treat skin conditions.

A photosensitive composition uses a specific photobase generator to improve sensitivity and reaction contrast.

A phenylacetylene polymer compensation film controls refractive index and birefringence through specific monomer structures.

Functionalized ionic liquids extract rare earth elements via oxygen-donating ligands, reducing waste from traditional solvent processes.

Planar anthraquinone cores enable DNA intercalation in rhein analogs, boosting anticancer activity while reducing cardiotoxic side effects.

Cyclic nitrogen treatment modifies vanadium phosphate catalysts to achieve high space-time-yield at lower reaction temperatures.

Bicyclic fused pyridine compounds inhibit TAM kinases, reducing cancer cell proliferation and metastasis while managing drug development complexity.

A sigma 1 receptor agonist compound in preservation solutions reduces cold ischemia damage and extends organ viability.

Ester-substituted quaternary nitrogen compounds maintain corrosion protection while lowering toxicity and increasing biodegradation rates.

A nitrogen-containing heterocyclic derivative enhances light emitting luminance and current efficiency in organic electroluminescence devices.

Optimized peroxide diluent systems maintain high active oxygen content while preventing crystallization and explosive risks at temperatures below -5°C.

Imidazole-bisepoxide bath chemistry deposits copper pillars with 5-8% TIR, eliminating nodular defects from non-uniform morphology.

Organic acid redox reactions sinter micron-scale copper particles below 150°C, preventing oxidation and achieving resistance below 0.04 ohm per square.

A segmented temperature process converts hydroxamic acid intermediates into high-purity cyclic imides for industrial oxidation catalysis.

Compounds with Formulas I and II inhibit Met kinase activity to block tumor growth signaling pathways.

A solid-phase synthesis method produces cyanuric acid-uracil complex zinc salt with uniform particle size using high shear milling.

A composite catalyst system with DMSO and acetonitrile solvents increases 5-hydroxymethylfurfural yield from glucose.

Unsaturated natural oils react with maleic anhydride to form adducts that produce thermoreversible gels without synthetic gelants.

Anti-masking control system dynamically adjusts sensitivity to reduce false alarms from background noise while maintaining intruder detection capability.

Small molecule modulators inhibit PCSK9 to increase LDL receptor levels, addressing insufficient LDL reduction from statin therapy.

Novel dithioester compound generates aralkyloxy radicals to control radical polymerization.

A sulfonium salt quencher controls acid diffusion in chemically amplified resist compositions.

A novel triarylamine compound boosts hole mobility and electron blocking to extend device lifetime.

Polyacylhydrazone dielectric layers enable precise laser ablation patterning while minimizing debris formation during microelectronic coating.

Diphenylpropenone compounds replace toxic traditional additives to increase weight and survival rates without environmental pollution.

Selective calcium channel agonists restore neuromuscular transmitter release, bypassing dose-limiting side effects of current immunosuppressant therapies.

Fused ring organic compounds optimize energy band gaps to address slow response time limitations in OLED devices.

A coumarin-based blue-fluorescent reagent enables selective imaging of lipid droplets in cells and tissues.

Formula I small molecules block NIK kinase activity, resolving inadequate disease management in autoimmune conditions.

Novel benzyloxypyridylcyclopropanecarboxylic acid compounds activate the GPR40 receptor to enhance insulin secretion and preserve pancreatic islet activity.

CCR2 modulating compounds limit oncogene over-expression and activate tumor suppressor genes to decrease tumor size and increase survival.